Surgery Partners Inc (SGRY) — Capital Reinvestment Ratio

Latest as of September 2025: 0.24x

Surgery Partners Inc (SGRY) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow ($83.60 Million) in capital expenditures ($19.80 Million). See Surgery Partners Inc balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

$83.60 Million
USD

Capital Expenditures

$19.80 Million
USD

Data as of

Sep 2025
Most recent filing

Surgery Partners Inc Capital Reinvestment Ratio (2012–2024)

This chart tracks Surgery Partners Inc's Capital Reinvestment Ratio across 13 annual periods. Check SGRY cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Surgery Partners Inc (2012–2024)

Year-by-year Capital Reinvestment Ratio for Surgery Partners Inc from 2012 to 2024. For live market cap and broader valuation context, see SGRY company net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.30x $300.10 Million $90.40 Million ▼ -0.3%
2023 0.30x $293.80 Million $88.80 Million ▼ -40.5%
2022 0.51x $158.80 Million $80.60 Million ▼ -23.2%
2021 0.66x $87.10 Million $57.60 Million ▲ +280.6%
2020 0.17x $246.90 Million $42.90 Million ▼ -69.4%
2019 0.57x $129.50 Million $73.60 Million ▲ +106.5%
2018 0.28x $144.60 Million $39.80 Million ▲ +12.5%
2017 0.24x $120.94 Million $29.60 Million ▼ -21.6%
2016 0.31x $125.24 Million $39.11 Million ▼ -21.1%
2015 0.40x $84.48 Million $33.44 Million ▼ -7.9%
2014 0.43x $21.95 Million $9.44 Million ▲ +408.4%
2013 0.08x $49.08 Million $4.15 Million ▼ -16.5%
2012 0.10x $46.38 Million $4.69 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow